QGEN Qiagen Projected Future Earnings

Symbol and logo of brand Qiagen NV (QGEN)

The price action of Qiagen N.V. (QGEN) securities reflects profit dynamics, which currently stand at 0.54. The business relies on the production of molecular analysis tools and scientific reagents, minimizing risks through a broad product portfolio. Patent protection and the high switching costs for clinics moving to alternative test systems block competitor access. Leadership in tuberculosis diagnostics and the launch of digital PCR platforms further strengthen its market position.

QGEN: Qiagen N.V. Expected Net Profit 07/04/2022 - 11/18/2026

Qiagen Corp - analytical breakdowns and key metrics (QGEN)

- share price and consensus valuation forecast:
General company analysis:Qiagen NV
Brand item of Qiagen Group

Qiagen N.V. (QGEN) leverages its gold-standard status in molecular diagnostics to effectively pass inflationary costs onto consumers, maintaining high business margins. An analysis of the forward profitability trend demonstrates the company's ability to generate future cash flow, where a stable or ascending line confirms the fundamental resilience of the asset's market value and the absence of operational stagnation.

Competitor analysis

Expected Profit Tempus AI|Net Profit Forecast IONS (Ionis)|Expected Profit Repligen Corp. (RGEN)|Company Profit Forecast Avidity Biosciences|Expected Profit CRISPR Therapeutics Corp CRSP|WGS: Net Profit Forecast|ultragenyx.com - Projected Future Earnings|Beam Therapeutics - Future Net Profit|SRPT: Projected Future Earnings|TWST (Twist Bio) - Expected Profit|TXG (10xgenomics.com) - Projected Future Earnings|Projected Future Earnings Intellia Therapeutics, Inc.|Projected Future Earnings STOK|Company Profit Forecast BioLife Solutions Inc|Expected Profit Wave Pharma WVE|Projected Future Earnings Maze Therapeutics Corp MAZE|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings